Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483 Response
  6. /
  7. SCA Pharmaceuticals, LLC
483 RESPONSE
•SCA Pharmaceuticals, LLC•October 20, 2023

FDA 483_RESPONSE - SCA Pharmaceuticals, LLC - October 20, 2023

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore SCA Pharmaceuticals, LLC
Record Details

This 483 RESPONSE record concerns SCA Pharmaceuticals, LLC, with an inspection on October 20, 2023.

Company
SCA Pharmaceuticals, LLC
Inspection Date
October 20, 2023
People
  • Lisa M. Harlan (Program Division Director)
  • Scott Luce
Open in Dashboard

ID · 910fa2fc-9042-43cb-a938-e5d86530779c

Violation Codes1
FD&C Act 503B(a)(10)(A)

Full citation text and observation details available on the Dashboard.

KeyPedia
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.